Levophacetoperane

Levophacetoperane
Clinical data
Routes of
administration
Oral
ATC code none
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
CAS Number 24558-01-8 YesY
PubChem (CID) 15706387
ChemSpider 32702188
UNII 3SZ9ZII529
Chemical and physical data
Formula C14H19NO2
Molar mass 233.31 g/mol
3D model (Jmol) Interactive image
  (verify)

Levophacetoperane (Lidépran, Phacétoperane) is a psychostimulant developed by Rhône-Poulenc in the 1950s.[1] The drug has been used as an antidepressant and anorectic.[2][3] It is the reverse ester of methylphenidate.

See also

References

  1. Joseph Nicole Marie; Jacob Robert Michel (15 March 1960). "Patent US 2928835 - New esters". Rhône-Poulenc.
  2. Delbeke, F. T.; Debackere, M. (26 March 1975). "Isolation and detection of methylphenidate, phacetoperane and some other sympatomimetic central nervous stimulants with special reference to doping". Journal of Chromatography A. 106 (2): 412–417. doi:10.1016/S0021-9673(00)93853-6. PMID 239015 via ScienceDirect.
  3. Eric Konofal; Bruno Figadere (5 February 2015). "Patent Application US 20150038533 - Phacetoperane for the treatment of attention-deficit hyperactivity disorder". Assistance Publique – Hôpitaux de Paris.


This article is issued from Wikipedia - version of the 8/17/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.